NRG1 and lung adenocarcinoma: As such, Odintsov and his colleagues established two cell line models from NRG1-rearranged (Neuregulin-1) lung adenocarcinoma samples and showed via transcriptome analysis the activation of the mTOR pathway in these NRG1 fusion-bearing samples.